Mayne Pharma Group Ltd has released a press release.
Mayne Pharma expands US dermatology portfolio
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- 2021 Mayne Pharma AGM Speeches
- 2021 Full Year Media Release
- 2021 Full Year Investor Presentation
- Class action proceeding
- FDA approval of novel oral contraceptive NEXTSTELLIS
Later from Mayne Pharma
- 2022 Half Year Investor Presentation
- Mayne Pharma reports 1HFY22 results
- 22/03/2022 Non Executive Director Appointment
- Mayne Pharma Group Limited - NON-EXECUTIVE DIRECTOR APPOINTMENT
- Mayne Pharma recipient of $4.8m Federal Government Grant
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma